View Clinical Trial (Medical Research Study)
The Effects of Neuromuscular Training on Balance in Patients With Multiple Sclerosis
| City: |
|
Gaylord |
| State: |
|
Michigan |
| Zip Code: |
|
49735 |
| Conditions: |
|
Multiple Sclerosis, Relapsing-Remitting |
| Purpose: |
|
Standing Balance, with and without blindfold, will be measured on patients with Multiple
Sclerosis using a Biodex Balance Scale.
A Twelve week intervention with one non impact aerobics group and one control group will be
performed.
Standing balance will then be retested on all subjects and the results will be statistically
compared.
|
| Study Summary: |
|
Standing Balance will be tested in 4 phases:
- On a firm surface eyes open
- On a frim surface eyes blindfolded
- On a foam surface eyes open
- On a foam surface eyes blindfolded
The aerobics classes will be conducted by a NIA (Non Impact Aerobics) instructor and will be
a combination of tai chi, slow movement dancing, stretching and modified yoga stretches.
|
| Criteria: |
|
Inclusion Criteria:
- Patients that were diagnosed by a neurologist with Relapsing Remitting Multiple
Sclerosis.
- EDSS scale between 1 and 6.
- Patients that are able to travel to and from a 12 week program location.
Exclusion Criteria:
- Patients that were diagnosed by a neurologist with primary or secondary progressive
multiple sclerosis.
- EDSS scale above 6
|
| NCT ID: |
|
NCT01453868 |
| Primary Contact: |
|
Principal Investigator
Donovan Adendorf, DC
Nelson Mandela Metropole University, Department of Health Sciences
Donovan Adendorf, DC
Phone: 989-731 2948
Email: adendorf@msn.com
|
| Backup Contact: |
|
Email: adendorf@msn.com
Donovan Adendorf
Phone: 989-858 2345
|
| Location Contact: |
|
Gaylord, Michigan 49735
United States
Donovan Adendorf, DC
Phone: 989-731-2948
Email: adendorf@msn.com
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|